144 related articles for article (PubMed ID: 8817542)
1. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
Huhman KL; Gillespie CF; Marvel CL; Albers HE
Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
Lall GS; Biello SM
Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor.
Golombek DA; Biello SM; Rendon RA; Harrington ME
Neuroreport; 1996 May; 7(7):1315-9. PubMed ID: 8817557
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
Huhman KL; Albers HE
Peptides; 1994; 15(8):1475-8. PubMed ID: 7700850
[TBL] [Abstract][Full Text] [Related]
5. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
[TBL] [Abstract][Full Text] [Related]
6. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
Yannielli PC; Harrington ME
J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
Soscia SJ; Harrington ME
Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
[TBL] [Abstract][Full Text] [Related]
9. Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleus.
Gamble KL; Ehlen JC; Albers HE
Brain Res Bull; 2005 May; 65(6):513-9. PubMed ID: 15862923
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro.
Biello SM; Golombek DA; Harrington ME
Neuroscience; 1997 Apr; 77(4):1049-57. PubMed ID: 9130786
[TBL] [Abstract][Full Text] [Related]
11. Responses to neuropeptide Y in adult hamster suprachiasmatic nucleus neurones in vitro.
Cutler DJ; Piggins HD; Selbie LA; Mason R
Eur J Pharmacol; 1998 Mar; 345(2):155-62. PubMed ID: 9600631
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studies.
Yannielli PC; Brewer JM; Harrington ME
Eur J Neurosci; 2004 Feb; 19(4):891-7. PubMed ID: 15009136
[TBL] [Abstract][Full Text] [Related]
13. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts.
Harrington ME; Hoque S
Neuroreport; 1997 Aug; 8(12):2677-80. PubMed ID: 9295099
[TBL] [Abstract][Full Text] [Related]
14. Tetrodotoxin blocks NPY-induced but not muscimol-induced phase advances of wheel-running activity in Syrian hamsters.
Huhman KL; Marvel CL; Gillespie CF; Mintz EM; Albers HE
Brain Res; 1997 Oct; 772(1-2):176-80. PubMed ID: 9406970
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythms.
Albers HE; Ferris CF
Neurosci Lett; 1984 Sep; 50(1-3):163-8. PubMed ID: 6548555
[TBL] [Abstract][Full Text] [Related]
16. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase.
Kallingal GJ; Mintz EM
Neurosci Lett; 2007 Jul; 422(1):59-63. PubMed ID: 17597298
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y, GABA and circadian phase shifts to photic stimuli.
Lall GS; Biello SM
Neuroscience; 2003; 120(4):915-21. PubMed ID: 12927198
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical effects of NPY in the suprachiasmatic nucleus.
Gamble KL; Paul KN; Karom MC; Tosini G; Albers HE
Eur J Neurosci; 2006 May; 23(9):2488-94. PubMed ID: 16706855
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
20. Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters.
Huhman KL; Babagbemi TO; Albers HE
Brain Res; 1995 Mar; 675(1-2):333-6. PubMed ID: 7796148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
